Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × semaglutide × Other × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

naloxegol 5 alvimopan 3 Metformin 3 tegaserod 2 Testosterone Propionate 2 Standard of Care 2 Radiotherapy 2 Liraglutide 2 Exenatide 2 Early Intervention, Educational 2 semaglutide 1 prucalopride 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 lime 1 dapagliflozin 1 cyclohexaneacetic acid 1 bicalutamide 1 acetaminophen, hydrocodone drug combination 1 Testosterone 1 Taxes 1 Tamoxifen 1 Tadalafil 1 Sugammadex 1 Sucralfate 1 Sodium-Glucose Transporter 2 Inhibitors 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Qsymia 1 Psychiatric Rehabilitation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05819853 2025-08-28

RESTORE

University of Colorado, Denver

Phase 3 Recruiting

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡